Sensorion Preclinical Development News Today

Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for

October 6, 2022

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce Sensorion's participation i...

United Kingdom City Of Christophe Tran Van Ba Institut Pasteur Noemie Djokovic Matthew Cole Jessica Hodgson

Source: pharmiweb.com

Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022

July 7, 2022

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the

United States France General Institut Pasteur Mary Jane Elliott Jessica Hodgson Catherine Leveau Otmane Boussif

Source: finanznachrichten.de

Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium an